Check out how Retispec’s AI platform can detect early signs of Alzheimer’s from a simple eye exam in this article featured in the MaRS newsletter. Retispec’s innovative technology can transform Alzheimer’s disease screening by making it easily accessible and timely.
Retispec is an OBIO® member, an alumnus of the BDSP™, CAAP®, H2BB™, HealthMINT™ and WiHI programs and presented at the OBIO® Investment Summit.